金山科研平台，产品价格货期咨询微信：jinshanbio Source:Mouse myeloma cell line, NS0-derived Accession #:Q8BX35 N-terminal Sequence Analysis:Met1 Structure:Disulfide-linked homodimer Purity:>95%, by SDS-PAGE under reducing conditions and visualized by silver stain. Predicted Molecular Mass:42.6 kDa (monomer) SDS-PAGE:57-60 kDa, reducing conditions Activity:Measured by its binding ability in a functional ELISA.When RecombinantMouse EDA2R/TNFRSF27/XEDAR FcChimera is coated at 0.1 µg/mL (100 µL/well), the concentration of RecombinantHuman EDA‑A2/EctodysplasinA2 (Catalog# 922-ED) that produces 50% of the optimal binding response is typically 3‑15ng/mL. Formulation:Lyophilized from a 0.2 µm filtered solution in PBS.See Certificate of Analysis for details. Molecule Information: EDA2R/TNFRSF27/XEDAR Long Name: Ectodysplasin A2 Receptor Aliases: EDAA2R; TNFRSF27; XEDAR Entrez Gene IDs: 60401 (Human); 245527 (Mouse) Background: EDA2R/TNFRSF27/XEDAR EDA2R, also known as TNFRSF27 or XEDAR (X-linked ectodysplasin receptor), is an X-linked member of the TNF receptor superfamily (TNFRSF). Within the TNFRSF, EDA2R shares the highest homologies with EDAR and TNFRSF19/TROY. EDA-A2 is the EDA2R ligand. EDA2R expression is principally found in embryonic hair follicles. EDA2R, EDAR, EDA-A1, and EDA-A2 have been associated with hypohidrotic ectodermal dysplasia (HED).